Literature DB >> 20606445

Ranking the harm of alcohol, tobacco and illicit drugs for the individual and the population.

Jan van Amsterdam1, Antoon Opperhuizen, Maarten Koeter, Wim van den Brink.   

Abstract

Drug policy makers continuously face a changing pattern of drug use, i.e. new drugs appear on the market, the popularity of certain drugs changes or drugs are used in another way or another combination. For legislative purposes, drugs have mostly been classified according to their addictive potency. Such classifications, however, lack a scientific basis. The present study describes the results of a risk assessment study where 19 recreational drugs (17 illicit drugs plus alcohol and tobacco) used in the Netherlands have been ranked by a Dutch expert panel according to their harm based on the scientific state of the art. The study applies a similar approach as recently applied by Nutt et al. [Lancet 2007;369:1047-1053], so that the results of both studies could be compared. The harm indicators scored are acute and chronic toxicity, addictive potency and social harm. The aim of this study is to evaluate whether the legal classification of drugs in the Netherlands corresponds with the ranking of the drugs according to their science-based ranking of harm. Based on the results, recommendations are formulated about the legal classification of recreational drugs at national and international level which serves a rational approach for drug control.
Copyright © 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20606445     DOI: 10.1159/000317249

Source DB:  PubMed          Journal:  Eur Addict Res        ISSN: 1022-6877            Impact factor:   3.015


  34 in total

1.  "I'm not afraid of those ones just 'cause they've been prescribed": perceptions of risk among illicit users of pharmaceutical opioids.

Authors:  Raminta Daniulaityte; Russel Falck; Robert G Carlson
Journal:  Int J Drug Policy       Date:  2012-03-13

Review 2.  Clinical applications of hallucinogens: A review.

Authors:  Albert Garcia-Romeu; Brennan Kersgaard; Peter H Addy
Journal:  Exp Clin Psychopharmacol       Date:  2016-08       Impact factor: 3.157

3.  Persistent cannabis dependence and alcohol dependence represent risks for midlife economic and social problems: A longitudinal cohort study.

Authors:  Magdalena Cerdá; Terrie E Moffitt; Madeline H Meier; HonaLee Harrington; Renate Houts; Sandhya Ramrakha; Sean Hogan; Richie Poulton; Avshalom Caspi
Journal:  Clin Psychol Sci       Date:  2016-03-22

Review 4.  The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act.

Authors:  Matthew W Johnson; Roland R Griffiths; Peter S Hendricks; Jack E Henningfield
Journal:  Neuropharmacology       Date:  2018-06-05       Impact factor: 5.250

5.  Increased Presence of Fentanyl in Cocaine-Involved Fatal Overdoses: Implications for Prevention.

Authors:  Michelle L Nolan; Sindhu Shamasunder; Cody Colon-Berezin; Hillary V Kunins; Denise Paone
Journal:  J Urban Health       Date:  2019-02       Impact factor: 3.671

6.  Pride, Shame, and the Trouble with Trying to Be Normal.

Authors:  Theodore K Gideonse
Journal:  Ethos       Date:  2015-12-02

7.  Adverse psychosocial outcomes associated with drug use among US high school seniors: a comparison of alcohol and marijuana.

Authors:  Joseph J Palamar; Michael Fenstermaker; Dimita Kamboukos; Danielle C Ompad; Charles M Cleland; Michael Weitzman
Journal:  Am J Drug Alcohol Abuse       Date:  2014-08-29       Impact factor: 3.829

8.  Low level of alcohol drinking among two generations of non-Western immigrants in Oslo: a multi-ethnic comparison.

Authors:  Ellen J Amundsen
Journal:  BMC Public Health       Date:  2012-07-23       Impact factor: 3.295

9.  Behavioral economic interactions between cannabis and alcohol purchasing: Associations with disordered use.

Authors:  Sean B Dolan; Tory R Spindle; Ryan Vandrey; Matthew W Johnson
Journal:  Exp Clin Psychopharmacol       Date:  2020-10-01       Impact factor: 3.157

10.  Psychedelics and mental health: a population study.

Authors:  Teri S Krebs; Pål-Ørjan Johansen
Journal:  PLoS One       Date:  2013-08-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.